Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenicity and virulence of Hepatitis B virus. | Virulence | 2022 | 35100095 | PubTator, text mining | PubMed |
| Procurement and Evaluation of Hepatocytes for Transplantation From Neonatal Donors After Circulatory Death. | Cell Transplant | 2022 | 35094608 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
Binding of Hepatitis B Virus Pre-S1 Domain-Derived Synthetic Myristoylated Peptide to Scavenger Receptor Class B Type 1 with Differential Properties from Sodium Taurocholate Cotransporting Polypeptide. | Viruses | 2022 | 35062309 | PubTator, text mining | PubMed |
| Gene expression profiles in Malpighian tubules of the vector leafhopper Psammotettix striatus (L.) revealed regional functional diversity and heterogeneity. | BMC Genomics | 2022 | 35057738 | PubTator, text mining | PubMed |
| Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery. | Biomedicines | 2022 | 35052874 | PubTator, text mining | PubMed |
| From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights. | Biomedicines | 2022 | 35052840 | PubTator, text mining | PubMed |
| The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment. | Curr Opin Gastroenterol | 2022 | 35034082 | PubTator, text mining | PubMed |
| Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy. | PLoS Pathog | 2022 | 35030230 | PubTator, text mining | PubMed |
| [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect]. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2022 | 35028672 | PubTator, text mining | PubMed |
| Analysis of the transcriptome of the needles and bark of Pinus radiata induced by bark stripping and methyl jasmonate. | BMC Genomics | 2022 | 35026979 | PubTator, text mining | PubMed |
| Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules. | Mol Ther Nucleic Acids | 2022 | 35024245 | PubTator, text mining | PubMed |
| Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway. | J Immunol | 2022 | 35022275 | PubTator, text mining | PubMed |
| 5' preS1 Mutations To Prevent Large Envelope Protein Expression from Hepatitis B Virus Genotype A or Genotype D Markedly Increase Polymerase-Envelope Fusion Protein. | J Virol | 2022 | 35019714 | PubTator, text mining | PubMed |
| [Hepatitis B vaccines-history, achievements, challenges, and perspectives]. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2022 | 35015108 | PubTator, text mining | PubMed |
| [Ten years of the National Reference Center for hepatitis B viruses and hepatitis D viruses in Giessen, Germany: activities and experiences]. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2022 | 35015105 | PubTator, text mining | PubMed |
HepG2-NIAS cells, a new subline of HepG2 cells that can enhance not only CYP3A4 activity but also expression of drug transporters and form bile canaliculus-like networks by the oxygenation culture via a collagen vitrigel membrane. | J Toxicol Sci | 2022 | 34987140 | PubTator, text mining | PubMed |
| Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection. | J Virol | 2022 | 34985994 | PubTator, text mining | PubMed |
| Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4. | Int J Biol Sci | 2022 | 34975318 | PubTator, text mining | PubMed |
| Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis. | J Hepatol | 2022 | 34958836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=47